🚀 VC round data is live in beta, check it out!
BIO-UV Valuation Multiples
Discover revenue and EBITDA valuation multiples for BIO-UV and similar public comparables like Envirologic, Comelf, Glunz & Jensen, Gosa FOM and more.
BIO-UV Overview
About BIO-UV
BIO-UV Group is a manufacturer of ultraviolet (UV) water treatment equipment in France. It designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) adapted to the number of applications. The company offers products for disinfecting swimming pools and private and collective hot tubs, treating wastewater, producing drinking water, treating bilge water from ships and water from aquariums.
Founded
2000
HQ
Employees
61
Website
Sectors
Financials (LTM)
EV
$36M
BIO-UV Financials
BIO-UV reported last 12-month revenue of $43M and EBITDA of $5M.
In the same LTM period, BIO-UV generated $5M in EBITDA and $1M in net income.
Revenue (LTM)
BIO-UV P&L
In the most recent fiscal year, BIO-UV reported revenue of $47M and EBITDA of $5M.
BIO-UV expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $43M | XXX | $47M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $28M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 61% | XXX | XXX | XXX |
| EBITDA | $5M | XXX | $5M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $1M | XXX | $37K | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | — | — | $20M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
BIO-UV Stock Performance
BIO-UV has current market cap of $22M, and enterprise value of $36M.
Market Cap Evolution
BIO-UV's stock price is $1.60.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $36M | $22M | 1.0% | XXX | XXX | XXX | $0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBIO-UV Valuation Multiples
BIO-UV trades at 0.8x EV/Revenue multiple, and 6.7x EV/EBITDA.
EV / Revenue (LTM)
BIO-UV Financial Valuation Multiples
As of April 19, 2026, BIO-UV has market cap of $22M and EV of $36M.
Equity research analysts estimate BIO-UV's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BIO-UV has a P/E ratio of 20.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $22M | XXX | $22M | XXX | XXX | XXX |
| EV (current) | $36M | XXX | $36M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | 6.7x | XXX | 7.3x | XXX | XXX | XXX |
| EV/EBIT | 17.7x | XXX | 14.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.3x | XXX | XXX | XXX |
| P/E | 20.2x | XXX | 592.1x | XXX | XXX | XXX |
| EV/FCF | 11.0x | XXX | 6.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BIO-UV Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
BIO-UV Margins & Growth Rates
BIO-UV's revenue in the last 12 month grew by 8%.
BIO-UV's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.4M for the same period.
BIO-UV's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BIO-UV's rule of X is 34% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
BIO-UV Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | (10%) | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 5% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 34% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 55% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
BIO-UV Public Comps
See public comps and valuation multiples for other Machinery comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| BIO-UV | XXX | XXX | XXX | XXX | XXX | XXX |
| Envirologic | XXX | XXX | XXX | XXX | XXX | XXX |
| Comelf | XXX | XXX | XXX | XXX | XXX | XXX |
| Glunz & Jensen | XXX | XXX | XXX | XXX | XXX | XXX |
| Gosa FOM | XXX | XXX | XXX | XXX | XXX | XXX |
| Lyckegard Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BIO-UV M&A Activity
BIO-UV acquired XXX companies to date.
Last acquisition by BIO-UV was on XXXXXXXX, XXXXX. BIO-UV acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by BIO-UV
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialBIO-UV Investment Activity
BIO-UV invested in XXX companies to date.
BIO-UV made its latest investment on XXXXXXXX, XXXXX. BIO-UV invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by BIO-UV
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BIO-UV
| When was BIO-UV founded? | BIO-UV was founded in 2000. |
| Where is BIO-UV headquartered? | BIO-UV is headquartered in France. |
| How many employees does BIO-UV have? | As of today, BIO-UV has over 61 employees. |
| Is BIO-UV publicly listed? | Yes, BIO-UV is a public company listed on Euronext Paris. |
| What is the stock symbol of BIO-UV? | BIO-UV trades under ALTUV ticker. |
| When did BIO-UV go public? | BIO-UV went public in 2018. |
| Who are competitors of BIO-UV? | BIO-UV main competitors are Envirologic, Comelf, Glunz & Jensen, Gosa FOM. |
| What is the current market cap of BIO-UV? | BIO-UV's current market cap is $22M. |
| What is the current revenue of BIO-UV? | BIO-UV's last 12 months revenue is $43M. |
| What is the current revenue growth of BIO-UV? | BIO-UV revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of BIO-UV? | Current revenue multiple of BIO-UV is 0.8x. |
| Is BIO-UV profitable? | Yes, BIO-UV is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of BIO-UV? | BIO-UV's last 12 months EBITDA is $5M. |
| What is BIO-UV's EBITDA margin? | BIO-UV's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of BIO-UV? | Current EBITDA multiple of BIO-UV is 6.7x. |
| What is the current FCF of BIO-UV? | BIO-UV's last 12 months FCF is $3M. |
| What is BIO-UV's FCF margin? | BIO-UV's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of BIO-UV? | Current FCF multiple of BIO-UV is 11.0x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.